- Entry
- $58.93
- Now
- $51.52 -12.6%
- Target
- —
- Score
- —
Novo Nordisk forecasts **2026 adjusted sales and operating profit to fall 5%–13%**, as U.S. pricing pressure and competition offset continued GLP-1 volume growth.
— ORIGINAL POST ·
Novo Nordisk Warns of 2026 Sales and Profit Decline as U.S. Pricing Pressure Mounts
· r/wallstreetbets
· Feb 3, 2026